Cancer: Page 4

Harvard Medical School, RareCyte developing multiplex imaging for clinical pathology
Multiplex imaging technology enables the integration of microscopic analysis with the visualization of molecular markers in individual cells.
June 26, 2023
Scientists Lab Microscope Social
Gene mutations linked to drug-resistant liver cancer
Certain gene mutations could help physicians predict which hepatocellular carcinoma patients are most likely to develop drug resistance to lenvatinib.
June 26, 2023
Liver Cancer Social
Next-gen Cologuard demonstrates 94% sensitivity, 91% specificity for colorectal cancer detection
The firm also entered collaborations related to next-generation technology for ultra-sensitive detection of molecular residual disease (MRD) and ongoing research, as well as for the development of its multicancer early detection (MCED) approach.
June 21, 2023
Exact Sciences Corporation Social
Proscia, Mindpeak collaborate on AI-enabled pathology workflows
The collaboration will bring together Mindpeak’s algorithms for immunohistochemistry (IHC) quantification and Proscia’s Concentriq Dx software platform
June 20, 2023
Lab Pathology Man Social
Quest Diagnostics completes acquisition of Haystack Oncology, adds MRD liquid biopsy to Dx portfolio
Quest expects next year to use the MRD technology in blood-based clinical lab testing services for solid tumor cancers.
June 21, 2023
Business Deal Corporate Social
With pilot program, FDA seeks to reduce risks of LDTs that identify cancer biomarkers
The agency said it has become increasingly concerned that some companion diagnostic tests made by laboratories that it has not authorized may not provide accurate and reliable test results.
June 20, 2023
Fda Button Social
Nanopore-nanobody sensing platform detects viral proteins, cancer biomarkers
Researchers combined a ClyA nanopore with nanobodies designed to bind to proteins associated with certain diseases; DNA linkers connected the nanopores and nanobodies.
June 19, 2023
Lab Scientists Social
Colorectal cancer growth and chemoresistance linked to specific protein in study
Colorectal cancer grows faster and becomes more resistant to common chemotherapy drugs when elevated levels of a specific protein are present.
June 16, 2023
Colorectal Cancer Social
Biocartis to lay off 140 people in company reorganization
The Mechelen, Belgium-based supplier of instruments and tests said the plan would reduce operating expenses by about 18 million euros annually.
June 15, 2023
Genetics Dna Money Social
Reveal Genomics highlights results for breast cancer predictive test in phase II clinical trial
Precision oncology firm Reveal Genomics announced that its HER2Dx genomic test for HER2+ breast cancer has been validated in the PHERGain phase II clinical trial.
June 15, 2023
Breast Mammo Social
Paige launches AI-based product suite for breast cancer diagnosis
The Paige Breast Suite comprises a group of AI tools designed to support each step of breast cancer diagnosis and streamline pathologists’ day-to-day workflows.
June 15, 2023
Pathology Digital Workstation Microscope Social
Danish National Genome Center selects Qiagen software for variant interpretation
The initiative is part of a larger personalized medicine strategy that aims to provide whole-genome sequencing as a standard-of-care for relevant patient groups in Denmark.
June 14, 2023
Dna Sequencing Social
Previous Page
Page 4 of 91
Next Page